DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Molybdenum is an investigational drug.
There have been 6 clinical trials for Molybdenum. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Metal Metabolism, Inborn Errors, Syndrome, and Preleukemia. The leading clinical trial sponsors are Alexion Pharma GmbH, Meabco A/S, and Centre for Probe Development and Commercialization.
There are twenty-six US patents protecting this investigational drug and one hundred and sixty-eight international patents.
Recent Clinical Trials for Molybdenum
|Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A||Alexion Pharma GmbH||Phase 2/Phase 3|
|A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients||Canadian Institutes of Health Research (CIHR)||N/A|
|A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients||Centre for Probe Development and Commercialization||N/A|
Top disease conditions for Molybdenum
Top clinical trial sponsors for Molybdenum
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Molybdenum||Start Trial||Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives||Societe Nationale Elf Aquitaine (Courbevoie, FR)||Start Trial|
|Molybdenum||Start Trial||Hydrodealkylation of C9+ aromatic compounds||Phillips Petroleum Company (Bartlesville, OK)||Start Trial|
|Molybdenum||Start Trial||Hydrodealkylation of C.sub.9 + aromatic compounds||Phillips Petroleum Company (Bartlesville, OK)||Start Trial|
|Molybdenum||Start Trial||Catalysts made from transition metal compounds and 4, 5-diphosphinoacridine-ligands||Studiengesellschaft Kohle mbH (Mulheim an der Ruhr, DE)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Molybdenum||European Patent Office||0404650||2009-06-19||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|